ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,473,366, issued on Nov. 18, was assigned to PHARMABCINE INC. (Daejeon, South Korea).
"Anti-TIE2 antibody and use thereof" was invented by Eun-Ah Lee (Daejeon, South Korea), Beom Yong Park (Daejeon, South Korea), Nu Ri Kang (Daejeon, South Korea), Cheonho Park (Daejeon, South Korea), Youngae Lee (Daejeon, South Korea), Do-Yun Kim (Daejeon, South Korea), Weon Sup Lee (Daejeon, South Korea) and Jin-San Yoo (Daejeon, South Korea).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to an antibody, which specifically binds to tyrosine-protein kinase receptor TIE-2 (TIE2) so as to possess functions of blood vessel normalization and stab...